This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Valeo Pharma Yönetim

Yönetim kriter kontrolleri 0/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Al Moghaddam

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesin/a
CEO görev süresiless than a year
CEO sahipliğin/a
Yönetim ortalama görev süresi1.6yrs
Yönetim Kurulu ortalama görev süresi1.8yrs

Son yönetim güncellemeleri

Recent updates

Market Might Still Lack Some Conviction On Valeo Pharma Inc. (TSE:VPH) Even After 55% Share Price Boost

Jun 14
Market Might Still Lack Some Conviction On Valeo Pharma Inc. (TSE:VPH) Even After 55% Share Price Boost

Market Cool On Valeo Pharma Inc.'s (TSE:VPH) Revenues Pushing Shares 31% Lower

Apr 20
Market Cool On Valeo Pharma Inc.'s (TSE:VPH) Revenues Pushing Shares 31% Lower

Valeo Pharma Inc. (TSE:VPH) Stocks Pounded By 33% But Not Lagging Industry On Growth Or Pricing

Mar 02
Valeo Pharma Inc. (TSE:VPH) Stocks Pounded By 33% But Not Lagging Industry On Growth Or Pricing

Investors Still Aren't Entirely Convinced By Valeo Pharma Inc.'s (TSE:VPH) Revenues Despite 68% Price Jump

Jan 17
Investors Still Aren't Entirely Convinced By Valeo Pharma Inc.'s (TSE:VPH) Revenues Despite 68% Price Jump

Valeo Pharma Inc. (TSE:VPH) Might Not Be As Mispriced As It Looks After Plunging 29%

Jun 08
Valeo Pharma Inc. (TSE:VPH) Might Not Be As Mispriced As It Looks After Plunging 29%

Analysts Have Just Cut Their Valeo Pharma Inc. (TSE:VPH) Revenue Estimates By 24%

Jun 24
Analysts Have Just Cut Their Valeo Pharma Inc. (TSE:VPH) Revenue Estimates By 24%

Earnings Update: Valeo Pharma Inc. (TSE:VPH) Just Reported And Analysts Are Trimming Their Forecasts

Jun 17
Earnings Update: Valeo Pharma Inc. (TSE:VPH) Just Reported And Analysts Are Trimming Their Forecasts

Have Insiders Been Buying Valeo Pharma Inc. (CSE:VPH) Shares This Year?

Feb 08
Have Insiders Been Buying Valeo Pharma Inc. (CSE:VPH) Shares This Year?

CEO

Al Moghaddam (57 yo)

less than a year

Görev süresi

Mr. Al Moghaddam, B. Com. CMA had been a Director at Valeo Pharma Inc. since March 21, 2024 until June 2024 and served as its Chief Development Officer since June 2024 until August 2024 and serves as its C...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Kyle Steiger
Senior VP & Chief Commercial Officer2.3yrsCA$388.21k0.020%
CA$ 872.5
Al Moghaddam
Chief Executive Officerless than a yearVeri yokVeri yok
Pascal Tougas
Chief Financial Officerless than a yearVeri yokVeri yok
Frédéric Dumais
Director of Communications & Investor Relationsno dataVeri yokVeri yok
Guy-Paul Allard
VP of Legal Affairs & Corporate Secretaryno dataVeri yok0%
CA$ 0
Jean Fournier
Head of Ophthalmology Business Unit2.3yrsVeri yokVeri yok

1.6yrs

Ortalama Görev Süresi

Deneyimli Yönetim: VPH 'un yönetim ekibi deneyimli olarak kabul edilmiyor ( 1.6 yıl), bu da yeni bir ekibin varlığını gösteriyor.


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Robert Raich
Independent Directorless than a yearVeri yok0.18%
CA$ 7.9k
Richard MacKay
Chairman of the Advisory Board & Director15.8yrsVeri yok16.44%
CA$ 730.0k
Steven Saviuk
Chairman21.7yrsCA$466.29k0.18%
CA$ 8.1k
Marc Leger
Independent Non-Executive Director2.6yrsVeri yok2.36%
CA$ 104.9k
Richard Lajoie
Independent Directorless than a yearVeri yokVeri yok
Charles Bisaillon
Independent Directorless than a yearVeri yokVeri yok

1.8yrs

Ortalama Görev Süresi

65yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: VPH 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilmiyor ( 1.8 yıllık ortalama görev süresi), bu da yeni bir yönetim kurulu olduğunu gösteriyor.